Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-072202
Filing Date
2025-07-30
Accepted
2025-07-30 16:45:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2522060d1_defa14a.htm DEFA14A 42732
  Complete submission text file 0001104659-25-072202.txt   43725
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38067 | Film No.: 251167793
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)